| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
PBX/knotted 1 homeobox 2 | 0.743 | 0.500 | 0.99 |
|
disease | 0.420 | None | 1.000 | 2 | 0 | 2011 | 2015 | ||||||||
|
serine incorporator 2 | 0.792 | 0.192 | 3.9E-13 |
|
disease | 0.420 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
catenin alpha 2 | 0.663 | 0.500 | 0.43 |
|
disease | 0.420 | None | 1.000 | 1 | 0 | 2014 | 2019 | ||||||||
|
potassium inwardly rectifying channel subfamily J member 6 | 0.615 | 0.692 | 0.54 |
|
disease | 0.410 | None | 1.000 | 2 | 0 | 2011 | 2013 | ||||||||
|
thrombospondin type 1 domain containing 7B | 0.890 | 0.154 | 2.6E-19 |
|
disease | 0.410 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
long intergenic non-protein coding RNA 2694 | 0.780 | 0.308 | 1.7E-02 |
|
disease | 0.410 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
dopamine receptor D2 | 0.436 | 0.846 | 0.75 |
|
disease | 0.400 | None | 0.800 | 5 | 0 | 1990 | 2019 | ||||||||
|
dopamine receptor D3 | 0.529 | 0.692 | 2.4E-03 |
|
disease | 0.400 | None | 0.800 | 5 | 0 | 1995 | 2018 | ||||||||
|
corticotropin releasing hormone receptor 1 | 0.517 | 0.769 | 3.8E-05 |
|
disease | 0.400 | None | 1.000 | 5 | 0 | 2005 | 2015 | ||||||||
|
dopamine receptor D4 | 0.517 | 0.577 | 9.3E-09 |
|
disease | 0.400 | None | 1.000 | 5 | 0 | 1995 | 2015 | ||||||||
|
ankyrin repeat and kinase domain containing 1 | 0.604 | 0.462 | 7.4E-12 |
|
disease | 0.400 | None | 0.800 | 5 | 0 | 2004 | 2017 | ||||||||
|
dopamine beta-hydroxylase | 0.511 | 0.846 | 3.3E-10 |
|
disease | 0.400 | None | 1.000 | 5 | 0 | 1981 | 2014 | ||||||||
|
cholinergic receptor muscarinic 2 | 0.585 | 0.615 | 0.18 |
|
disease | 0.400 | None | 1.000 | 5 | 0 | 2004 | 2018 | ||||||||
|
proopiomelanocortin | 0.356 | 0.846 | 1.2E-04 |
|
disease | 0.400 | None | 0.800 | 5 | 0 | 1989 | 2019 | ||||||||
|
brain derived neurotrophic factor | 0.345 | 0.923 | 0.66 |
|
disease | 0.400 | None | 0.400 | 5 | 0 | 2004 | 2020 | ||||||||
|
solute carrier family 6 member 3 | 0.453 | 0.885 | 1.00 |
|
disease | 0.400 | None | 1.000 | 5 | 0 | 1995 | 2019 | ||||||||
|
monoamine oxidase A | 0.465 | 0.769 | 1.00 |
|
disease | 0.400 | None | 1.000 | 5 | 0 | 1995 | 2018 | ||||||||
|
aldo-keto reductase family 1 member A1 | 0.510 | 0.846 | 6.7E-07 |
|
disease | 0.400 | None | 1.000 | 5 | 0 | 1977 | 2019 | ||||||||
|
opioid receptor kappa 1 | 0.555 | 0.615 | 4.1E-05 |
|
disease | 0.400 | None | 0.800 | 5 | 0 | 2004 | 2018 | ||||||||
|
5-hydroxytryptamine receptor 1B | 0.551 | 0.769 | 0.19 |
|
disease | 0.400 | None | 1.000 | 5 | 0 | 1998 | 2019 | ||||||||
|
monoamine oxidase B | 0.533 | 0.808 | 1.00 |
|
disease | 0.390 | None | 1.000 | 5 | 0 | 1994 | 2014 | ||||||||
|
aldehyde dehydrogenase 1 family member A1 | 0.460 | 0.846 | 0.95 |
|
disease | 0.390 | None | 1.000 | 5 | 0 | 1983 | 2017 | ||||||||
|
corticotropin releasing hormone | 0.439 | 0.808 | 0.72 |
|
disease | 0.390 | None | 1.000 | 5 | 0 | 2004 | 2018 | ||||||||
|
glutamate ionotropic receptor NMDA type subunit 2B | 0.510 | 0.692 | 1.00 |
|
disease | 0.380 | None | 0.800 | 5 | 0 | 2003 | 2017 | ||||||||
|
cannabinoid receptor 1 | 0.446 | 0.808 | 0.51 |
|
disease | 0.370 | None | 1.000 | 5 | 0 | 2002 | 2014 |